Statin use and all-cause and cancer mortality: BioBank Japan cohort

Hiroshi Yokomichi(University of Yamanashi), Masako Ueyama, Zentaro Yamagata(University of Yamanashi), Michihiro Ogasawara, Nobuyoshi Higa(Fukuoka Tokushukai Hospital), Satoshi Asai, Akiko Nagai(Tokyo University of Science), Satoshi Nagayama(The Cancer Institute Hospital), Hirotoshi Ohmura(Juntendo University), Wataru Obara(Iwate Medical University), Akihiro Inui(Juntendo University), Yasuo Takahashi(Nihon University), Akiko Tamakoshi(Hokkaido University), Shiro Minami(Nippon Medical School), Naoya Emoto(Nippon Medical School), Hideo Kusuoka, Hideki Ito(Tokyo Metropolitan Tama-Hokubu Medical Center), Satoshi Ugi(Shiga University of Medical Science), Hiroshi Maegawa(Shiga University of Medical Science), Sunao Matsubayashi(Fukuoka Tokushukai Hospital), Koichi Matsuda(The University of Tokyo), Michiaki Kubo(RIKEN Center for Integrative Medical Sciences), Seijiro Mori, Makoto Hirata(The University of Tokyo), Toshiharu Ninomiya(Kyushu University), Akira Yamada, Ken Kodama(Osaka International Cancer Institute), Yoshio Miki(Japanese Foundation For Cancer Research), Yusuke Nakamura(Rissho University), Yukihiro Koretsune(Osaka National Hospital), Tomoaki Fujioka(Iwate Medical University), Kazuo Misumi(Fukuoka Tokushukai Hospital), Yutaka Kiyohara(Hisayama Research Institute For Lifestyle Diseases), Kei Matsuura(Fukuoka Tokushukai Hospital), Akihide Masumoto(Aso Iizuka Hospital), Yasuko Nishizawa, Kaori Muto(Tokyo University of Science), Mitsu- hiko Moriyama, Hitoshi Sugihara(Nippon Medical School)
Journal of Epidemiology
February 11, 2017
Cited by 34


Related Papers